Eva Aguilera
Overview
Explore the profile of Eva Aguilera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calleja R, Aguilera E, Duran M, Perez de Villar J, Padial A, Luque-Molina A, et al.
Transl Gastroenterol Hepatol
. 2024 Nov;
9:72.
PMID: 39503025
Background And Objective: Liver transplantation is the gold standard treatment for patients with hepatocellular carcinoma (HCC). Current allocation systems face a complex issue due to the imbalance between available organs...
2.
Garcia-Loza I, Perna-Barrull D, Aguilera E, Almenara-Fuentes L, Gomez-Munoz L, Greco D, et al.
J Autoimmun
. 2024 Mar;
145:103196.
PMID: 38458075
Type 1 diabetes (T1D) results from a breakdown in immunological tolerance, with pivotal involvement of antigen-presenting cells. In this context, antigen-specific immunotherapies have been developed to arrest autoimmunity, such as...
3.
Reyes R, Moreno-Perez O, Tejera-Perez C, Brito-Sanfiel M, Pines P, Aguilera E, et al.
Diabetes Metab
. 2023 Nov;
50(1):101496.
PMID: 37981195
No abstract available.
4.
Bellido V, Aguilera E, Cardona-Hernandez R, Diaz-Soto G, Gonzalez Perez de Villar N, Picon-Cesar M, et al.
J Diabetes Sci Technol
. 2022 Apr;
17(5):1326-1336.
PMID: 35470692
New metrics for assessing glycemic control beyond HbA1c have recently emerged due to the increasing use of continuous glucose monitoring (CGM) in diabetes clinical practice. Among them, time in range...
5.
Villalba A, Rodriguez-Fernandez S, Perna-Barrull D, Ampudia R, Gomez-Munoz L, Pujol-Autonell I, et al.
Sci Rep
. 2020 Nov;
10(1):18927.
PMID: 33144616
Type 1 diabetes is an autoimmune disease caused by the destruction of the insulin-producing β-cells. To revert type 1 diabetes, the suppression of the autoimmune attack should be combined with...
6.
Villalba A, Rodriguez-Fernandez S, Perna-Barrull D, Ampudia R, Gomez-Munoz L, Pujol-Autonell I, et al.
Front Endocrinol (Lausanne)
. 2020 Jun;
11:258.
PMID: 32477262
Type 1 diabetes is an autoimmune disease caused by the destruction of the insulin-producing β-cells. An ideal immunotherapy should combine the blockade of the autoimmune response with the recovery of...
7.
Rodriguez-Fernandez S, Murillo M, Villalba A, Perna-Barrull D, Cano-Sarabia M, Gomez-Munoz L, et al.
Front Immunol
. 2019 Dec;
10:2811.
PMID: 31849983
Type 1 diabetes (T1D) is prompted by defective immunological tolerance, an event in which dendritic cells (DCs) are crucial as immune response orchestrators. In fact, they contribute to maintaining tolerance...
8.
Chico A, Aguilera E, Ampudia-Blasco F, Bellido V, Cardona-Hernandez R, Escalada F, et al.
J Diabetes Sci Technol
. 2019 May;
14(1):155-164.
PMID: 31081362
The flash glucose monitoring (FGM) system FreeStyle Libre® is a device that measures interstitial glucose in a very simple way and indicates direction and speed of glucose change. This allows...
9.
Deiss D, Szadkowska A, Gordon D, Mallipedhi A, Schutz-Fuhrmann I, Aguilera E, et al.
Diabetes Technol Ther
. 2019 Apr;
21(5):254-264.
PMID: 31021180
The use of real-time continuous glucose monitoring (rtCGM) systems has proved to positively impact the management of type 1 diabetes with the potential to lower HbA1c, reduce frequency and time...
10.
Granado-Casas M, Alcubierre N, Martin M, Real J, Ramirez-Morros A, Cuadrado M, et al.
Eur J Nutr
. 2018 Jul;
58(6):2271-2279.
PMID: 30019088
Purpose: We aimed to assess food intake and adherence to the Mediterranean Diet in patients with T1D compared with nondiabetic individuals. Methods: This was an observational, multicenter study in 262...